113 related articles for article (PubMed ID: 22826825)
41. The influence of the route of oestrogen administration on serum levels of cortisol-binding globulin and total cortisol.
Qureshi AC; Bahri A; Breen LA; Barnes SC; Powrie JK; Thomas SM; Carroll PV
Clin Endocrinol (Oxf); 2007 May; 66(5):632-5. PubMed ID: 17492949
[TBL] [Abstract][Full Text] [Related]
42. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.
Canonico M; Fournier A; Carcaillon L; Olié V; Plu-Bureau G; Oger E; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F; Scarabin PY
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):340-5. PubMed ID: 19834106
[TBL] [Abstract][Full Text] [Related]
43. Kinetics and pharmacology of estrogens in pre- and postmenopausal women.
Anderson F
Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():55-64. PubMed ID: 8499960
[TBL] [Abstract][Full Text] [Related]
44. Clinical pharmacology and differential cognitive efficacy of estrogen preparations.
Gleason CE; Carlsson CM; Johnson S; Atwood C; Asthana S
Ann N Y Acad Sci; 2005 Jun; 1052():93-115. PubMed ID: 16024754
[TBL] [Abstract][Full Text] [Related]
45. EMAS position statement: Managing the menopause in the context of coronary heart disease.
Schenck-Gustafsson K; Brincat M; Erel CT; Gambacciani M; Lambrinoudaki I; Moen MH; Tremollieres F; Vujovic S; Rozenberg S; Rees M;
Maturitas; 2011 Jan; 68(1):94-7. PubMed ID: 21156341
[TBL] [Abstract][Full Text] [Related]
46. [Hormone substitution therapy in menopause and risk of breast cancer].
Colin C
Rev Fr Gynecol Obstet; 1991 Jan; 86(1):27-8. PubMed ID: 2068481
[TBL] [Abstract][Full Text] [Related]
47. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy.
Ettinger B; Pressman A
Am J Manag Care; 1999 Jun; 5(6):779-85. PubMed ID: 10538456
[TBL] [Abstract][Full Text] [Related]
48. Plausible--yes. But ..
Fenton A; Panay N
Climacteric; 2009 Dec; 12(6):461-2. PubMed ID: 19905898
[No Abstract] [Full Text] [Related]
49. Breast cancer risk in postmenopausal women using estrogen-only therapy.
Lyytinen H; Pukkala E; Ylikorkala O
Obstet Gynecol; 2006 Dec; 108(6):1354-60. PubMed ID: 17138766
[TBL] [Abstract][Full Text] [Related]
50. Not to be sniffed at.
Andrews G
Nurs Stand; 2001 Oct 10-16; 16(4):16. PubMed ID: 11977815
[No Abstract] [Full Text] [Related]
51. Deep vein thrombosis in a transgender woman.
Chan W; Drummond A; Kelly M
CMAJ; 2017 Apr; 189(13):E502-E504. PubMed ID: 28385895
[No Abstract] [Full Text] [Related]
52. Advantages and disadvantages of estrogen treatment by transdermal or oral administration.
Rozenbaum H
Eur J Obstet Gynecol Reprod Biol; 1996 Mar; 65(1):33-7. PubMed ID: 8706954
[No Abstract] [Full Text] [Related]
53. The safety of oral versus transdermal estrogen.
Black D
Menopause; 2020 Nov; 27(11):1328-1329. PubMed ID: 33110050
[TBL] [Abstract][Full Text] [Related]
54. Risk of venous thrombosis with hormone replacement therapy.
Scarabin PY
Lancet; 1996 Dec; 348(9042):1668. PubMed ID: 8962022
[No Abstract] [Full Text] [Related]
55. Tapering versus cold turkey: symptoms versus successful discontinuation of menopausal hormone therapy.
Suffoletto JA; Hess R
Menopause; 2009; 16(3):436-7. PubMed ID: 19276996
[No Abstract] [Full Text] [Related]
56. Efficacy of pulsed estrogen therapy in relatively younger patients with surgically induced menopause.
Yesildaglar N; Erkaya S; Uygur D; Göl K; Bingöl B; Günenç Z
Hum Reprod; 2004 Jan; 19(1):210-3. PubMed ID: 14688184
[TBL] [Abstract][Full Text] [Related]
57. Type of hormone replacement therapy and risk of venous thromboembolism.
Roberts H
BMJ; 2008 May; 336(7655):1203-4. PubMed ID: 18495630
[TBL] [Abstract][Full Text] [Related]
58. Timing of menopausal hormone therapy and myocardial infarction.
Stuenkel CA
Menopause; 2015 Jun; 22(6):584-6. PubMed ID: 25871003
[No Abstract] [Full Text] [Related]
59. Estrogen and the risk of coagulopathy.
Lobo RA
Am J Med; 1992 Mar; 92(3):283-5. PubMed ID: 1546727
[No Abstract] [Full Text] [Related]
60. [2002-2012: A cursed decade for estrogens].
Lesur A
Gynecol Obstet Fertil; 2012 Nov; 40(11):631-3. PubMed ID: 23099028
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
